|Videos|April 11, 2017

The Importance of Rapid Diagnostic Testing

Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains the importance of rapid diagnostic testing.

Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains the importance of rapid diagnostic testing.

Interview Transcript (slightly modified for readability)

“The importance of rapid diagnostic tests and antimicrobial treatment to guide care starts with what we want to deliver. We want to deliver value in the healthcare we provide. In order to provide value, you need to demonstrate that you’re going to have better outcomes with the technology that you’re going to use, at a lower cost at the end of the full cycle of care of the patient.

If [I’m] treating someone with an infection and I can find what kind of infection that patient has, sooner, faster, if I know if it’s a virus or bacteria, I can make a comprehensive, well-educated and informed decision [and say], ‘Hey, you don’t need an antibiotic, you have a virus. Maybe we can treat this virus with reassurance, or maybe we need to give you an antiviral, depending on if it’s flu, for example.’ If it’s bacteria, I can [say], ‘Hey, it’s bacteria, and we can narrow or streamline therapy according to the pathogen.’

[Rapid diagnostic testing] really helps you make cost-effective decisions that should improve the patient outcome.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.